Perhaps something isn’t always better than nothing
Dr Laura Duggan discusses recent research quantifying airborne particle exposure when using aerosol containment devices for intubation.
Tag covid-19
Dexamethasone good? Science by press release bad!
Why science by press release is bad, despite optimism about the findings of the Recovery trial and the role of dexamethasone in the management of COVID-19.
COVID-19 miniRAGE with Hicks and Brindley
Dr Chris Hicks (@humanfact0rz) and Prof Peter Brindley (@docpgb) discuss key issues and controversies in the care of critically ill patients with COVID-19 in a miniRAGE podcast.
Overcoming uncertainty in the Age of COVID-19
Overcoming uncertainty in the Age of COVID-19. Part 7 of the "COVID-19: Keeping the baby in the bath" series.
Novel drug therapies and COVID-19 clinical trials
Novel drug therapies and clinical research. Part 6 of the "COVID-19: Keeping the baby in the bath" series
MacGyverism and “hacking COVID-19”
Implementation ,testing, and development of innovations into clinical practice. Part 5 of the "COVID-19: Keeping the baby in the bath" series.
COVID-19: “To PEEP, or not to PEEP”?
Part 4 of "COVID-19: Keeping the baby in the bath" discussing the setting of positive end expiratory pressure (PEEP) in critically ill COVID-19 patients.
Is COVID-19 ARDS? What about lung compliance?
Part 3 of the "COVID-19: Keeping the baby in the bath" series discussing whether COVID-19 is part of acute respiratory distress syndrome (ARDS) and the importance of lung compliance.
SARS-CoV-2 infection and pathogenesis
SARS-CoV-2 infection and pathogenesis: hyperinflation, thrombosis and resp failure (proposed mechanisms). Ilustraciones clínicas para la educación médica
Survey Shoutout
Shoutouts for the COVID-19 Critical Care Staff Wellbeing Survey; and ED screening and patient flow management of suspected COVID-19 patients
Imaging of COVID-19 pneumonia: a critical care perspective
Overview of lung imaging for COVID-19 pneumonia, from a critical care perspective (Critical Care Compendium)
SARS-CoV-2 phenotypes
Some experts divide patients in two separate phenotypes: The “L” phenotype characterized by a hypoxemic failure and “low elastance” lungs (high compliance) and the “H” phenotype with “high elastance and recoil” lungs (lower compliance).